Showing 319 results
Amy Sinden | June 27, 2012
Letter to EPA Nominating BPA for Fourth Contaminant Candidate List
Matt Shudtz, Rena Steinzor | June 15, 2012
Letter to EPA re nominees to new advisory committee on IRIS
Aimee Simpson | April 18, 2012
Comments to FDA on BPA
James Goodwin, Nicholas Vidargas, Sidney A. Shapiro | March 8, 2012
The Truth About Torts: Defensive Medicine and the Unsupported Case for Medical Malpractice ‘Reform,’ CPR White Paper 1203
March 7, 2012
March 8, 2012, New CPR White Paper Takes on Myth of ‘Defensive Medicine’ as a Significant Driver of Medical Malpractice Insurance Premiums and Health Care Costs; Authors Say Defensive Medicine’s Impact on Overall Costs Is Slight.
January 26, 2012
January 26, 2012, U.S. Should Take Steps Now to Begin Protecting Public from BPA, a Ubiquitous Endocrine-Disrupting Chemical, Says New CPR Report.
Aimee Simpson, Matt Shudtz, Rena Steinzor, Thomas McGarity | January 25, 2012
Protecting the Public from BPA: An Action Plan for Federal Agencies
Matt Shudtz, Sidney A. Shapiro, Thomas McGarity, Wendy Wagner | January 12, 2012
Comments to NIOSH re carcinogen classification system and recommended exposure limits
Matt Shudtz, Rena Steinzor | December 22, 2011
Letter to EPA re IRIS toxics database, response to American Chemistry Council misinterpretation